Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

Autor(en)

E. L. Zeilinger, C. Oppenauer, M. Knefel, V. Kantor, C. Schneckenreiter, S. Lubowitzki, K. Krammer, C. Popinger, A. Kitta, L. Kum, F. Adamidis, M. Unseld, E. K. Masel, T. Füreder, S. Zöchbauer-Müller, R. Bartsch, M. Raderer, Gerald Prager, M. T. Krauth, W. R. Sperr, E. Porpaczy, P. B. Staber, P. Valent, A. Gaiger

Abstrakt

Aims Cancer patients often present with psychological symptoms that affect their quality of life, physical health outcomes and survival. Two of the most frequent psychiatric comorbidities are anxiety and depression. However, the prevalence of these disorders among cancer patients remains unclear, as studies frequently report varying rates. In the present study, we aimed to provide robust point estimates for the prevalence of anxiety and depression for both a mixed cancer sample and for 13 cancer types separately, considering confounding variables. Methods In a sample of 7509 cancer outpatients (51.4% female), we used the Hospital Anxiety and Depression Scale to assess rates of anxiety and depression. Applying ordinal logistic regression models, we compared the prevalence of anxiety and depression between different cancer types, controlling for age and gender. Results About one third of our sample showed symptoms of anxiety (35.2%) or depression (27.9%), and every sixth patient had a very likely psychiatric condition, with women being more frequently affected. Elderly patients more often showed signs of depression. The prevalence of anxiety and depression was significantly higher in lung and brain cancer patients, than in other cancer patients. Lowest depression rates were found in breast cancer patients. Conclusions The prevalence of anxiety and depression is high in cancer patients. Type of cancer is an important predictor for anxiety and depressive symptoms, with lung and brain cancer patients being highly burdened. Considering a personalised medicine approach, physicians should take into account the high prevalence of psychiatric comorbidities and include psychiatric consultations in the treatment plan.

Organisation(en)

Institut für Klinische und Gesundheitspsychologie

Externe Organisation(en)

Medizinische Universität Wien, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften

Journal

Epidemiology and Psychiatric Sciences

Band

31

ISSN

2045-7960

DOI

https://doi.org/10.1017/S2045796022000592

Publikationsdatum

10-2022

Peer-reviewed

Ja

ÖFOS 2012

501010 Klinische Psychologie

Schlagwörter

ASJC Scopus Sachgebiete

Public Health, Environmental and Occupational Health, Psychiatry and Mental health, Epidemiology

Sustainable Development Goals

SDG 3 – Gesundheit und Wohlergehen

Link zum Portal

https://ucrisportal.univie.ac.at/de/publications/af8b2f66-f091-400f-8f01-ad04b84e7872